We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.94B
AUM Growth
-$256M
(-4.9%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$52.6M |
| 2 |
UnitedHealth
UNH
|
+$48.5M |
| 3 |
Eli Lilly
LLY
|
+$40.2M |
| 4 |
Bank of America
BAC
|
+$33.6M |
| 5 |
Pfizer
PFE
|
+$32.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$55.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$45M |
| 3 |
Zimmer Biomet
ZBH
|
+$35.5M |
| 4 |
Cooper Companies
COO
|
+$35.5M |
| 5 |
Roper Technologies
ROP
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.89% |
| 2 | Technology | 24.22% |
| 3 | Financials | 21.01% |
| 4 | Communication Services | 9.7% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$3.9T
| $219M | 4.44% |
7,097,880
-511,580
| -7% | -$15.7M |
|
2
Apple
AAPL
$4.89T
| $214M | 4.33% |
7,752,680
-423,644
| -5% | -$12.4M |
|
|
3
Pfizer
PFE
$140B
| $159M | 3.22% |
5,338,350
+1,025,998
| +24% | +$32.9M |
|
4
Chubb
CB
$140B
| $90.2M | 1.83% |
872,274
-51,430
| -6% | -$5.38M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $86.8M | 1.76% |
965,197
-7,396
| -0.8% | -$679K |
|
6
Arch Capital
ACGL
$36.1B
| $83.5M | 1.69% |
3,410,796
-56,478
| -2% | -$1.32M |
|
7
Medtronic
MDT
$107B
| $77.5M | 1.57% |
1,157,992
-39,581
| -3% | -$2.92M |
|
8
Johnson & Johnson
JNJ
$634B
| $71M | 1.44% |
760,418
+139,125
| +22% | +$13.5M |
|
9
Markel Group
MKL
$25B
| $67.8M | 1.37% |
84,564
-3,798
| -4% | -$3.21M |
|
|
10
Eli Lilly
LLY
$1.07T
| $67.4M | 1.36% |
805,953
+475,953
| +144% | +$40.2M |
|
11
Visa
V
$677B
| $66.8M | 1.35% |
960,179
-69,883
| -7% | -$4.99M |
|
12
JPMorgan Chase
JPM
$939B
| $65.5M | 1.33% |
1,074,830
+37,462
| +4% | +$2.45M |
|
13
Intel
INTC
$464B
| $63.1M | 1.28% |
2,094,939
+78,409
| +4% | +$2.27M |
|
14
Accenture
ACN
$89.9B
| $61M | 1.23% |
620,584
+33,690
| +6% | +$3.34M |
|
15
Microsoft
MSFT
$2.84T
| $55.6M | 1.13% |
1,257,438
-183,557
| -13% | -$8.24M |
|
16
Citigroup
C
$222B
| $53.5M | 1.08% |
1,078,913
-88,802
| -8% | -$4.85M |
|
|
QVCGA
17
DELISTED
QVC Group Inc Series A
QVCGA
| $51.3M | 1.04% |
40,282
+1,055
| +3% | +$1.45M |
|
18
Booz Allen Hamilton
BAH
$8.7B
| $50.8M | 1.03% |
1,937,083
+220,181
| +13% | +$5.88M |
|
19
PepsiCo
PEP
$186B
| $50.4M | 1.02% |
534,189
+5,133
| +1% | +$488K |
|
|
20
UnitedHealth
UNH
$382B
| $49.6M | 1% |
427,750
+405,000
| +1,780% | +$48.5M |
|
21
Carnival Corporation Ltd
CCL
$36.1B
| $49.2M | 1% |
989,836
+189,816
| +24% | +$9.66M |
|
22
Aon
AON
$77.3B
| $47.8M | 0.97% |
539,043
+4,394
| +0.8% | +$425K |
|
23
TE Connectivity
TEL
$58.8B
| $46.7M | 0.95% |
780,056
+386,555
| +98% | +$23.5M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $46.5M | 0.94% |
+171,100
| New | +$52.6M |
|
25
Elevance Health
ELV
$81.9B
| $46.2M | 0.94% |
330,184
-8,442
| -2% | -$1.27M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.
- Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
- Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
- Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
- Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
- Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
- Polar Capital opened 46 new positions and closed 39 in Q3 2015.
- Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.
Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.